Prophylactic for young cattle

 

(57) Abstract:

The invention relates to veterinary medicine and can be used for the prevention of gastrointestinal disease of young cattle. The invention consists in the application shell pine nuts into a fine powder as a means of preventive therapy of gastrointestinal diseases of calves. Use reduces the incidence and improve the safety of young cattle. 5 table.

The invention relates to veterinary medicine, refers to a means of preventive therapy for young cattle and can be used to improve its safety and viability.

Preventive therapy is a complex of events that prevented pathological conditions of the disease, with the use of normalizing digestion, metabolism, preventing depletion of the body's defenses. Known means of preventive therapy containing biologically active substances of vegetable origin, for example, antideprin [1], pectoris [2]. Part of the famous tools are biologically active substances with

The purpose of the invention is the expansion of the means of preventive therapy for young cattle.

This goal is achieved by the application as a preventive measure shell pine nuts (RMS). RMS is a complex natural organo-mineral complex, involving dozens of different chemical compounds (table 1).

As can be seen from table 1, the main groups of biologically active substances that contribute to the spectrum of RMS are tanney with styptic, anti-inflammatory, fungo and bacteriostatic action, contributing to the sealing of the lining of the stomach (abomasum), which makes it insensitive to stimulation; flavonoids with P-vitamin activity, inhibiting hyaluronidase, which provides anti-inflammatory action, and strengthen the vascular wall, which reduces the permeability and fragility of capillaries. In the inorganic (mineral) part SKO, component to 1.26% of the total weight, contains macro - and trace elements in bioavailable form. Especially high content in RMS potassium (3300,00 mg/kg), magnesium (650,00 mg/kg), phosphorus (680,00 mg/kg), iron (140,00 mg/kg), aluminum (70,00 mg/kg), to the 1,60% of the total mass, presents a poly (cellulose, pectin) and monosaccharides.

RMSE is fed from the first days of life in the next 10 days in the form of fine powder with a moisture content of not more than 8.2%.

The feasibility of the invention was determined in the research and production experience in the sector with satisfactory living conditions and feeding cows. Cows received 10-11 food.ed. In the structure of the hay diet was 10%, haylage - 30, silo - 15-the roots - 15, concentrates - 30%. Calves are born with a live weight of 30-32 kg Calving took place in the maternity ward. The quality analysis of the feed showed that hay belonged to the second and third classes, silage corn and hay are contained 18-31% butyric acid, reduced lactic acid, excess of calcium and phosphorus deficiency. Summer in the structure of the diet was dominated by the forage grasses. According to the results of analysis of diets found that they are defective in the stall period, but in the content of biologically active substances rations compliance with the norms of feeding.

The invention is illustrated by examples.

Example 1. In terms of the value of a diet of cow-mothers (summer) on the principle of analogues of the formation of the groups were fed in accordance with the technology growing 3 times per day at the rate of 1.5-2.0 l of colostrum (milk) for each feeding, and the first time maternal colostrum was drinking no later than 1.5 hours after birth. Calves experimental groups for 20-30 minutes until the second feeding for 10 days was given inside the powder RMS at a dose of 2.0, 4.0 and 6.0 g respectively. Before giving the dose of powder RMSE was dissolved in 100-150 ml of boiled and cooled to a temperature of 38-39°With water. For calves conducted observations, take into account the clinical condition, the palatability of feed and function of the digestive system. The results are presented in table 2.

It is established that calves after birth almost immediately stood up, they appeared well-defined sucking reflex, they had a good appetite. Temperature, pulse, respiration in calves of all groups were within the limits of physiological norm and was on its upper border: indicators of body temperature and breathing rate was 38.6°C and 36 breaths per minute, heart rate of 120 beats/min As can be seen from table 2, the RMSE does not have any negative effect on the health of the calves. Thus, in the control group ill 6 out of 10 calves (60,0%), experienced in - 2 out of 10 calves (20,0%). While the calves of the control group was pereboleli severe, as a result, the waste was 20.0%, and the safety - 80,0%.

Example 2. In terms of inferiority (deficit group of newborn calves birth weight 28-30 kg 10 goals in each of experiments and control. The scheme of experiment as in example 1. The results are presented in tables 3 and 4.

Found that calves born sluggish, inactive, did not seek to receive colostrum, sucking reflex was weakly expressed. Temperature, pulse, respiration in calves of all groups were within the limits of physiological norm and was on its lower border: indicators of body temperature and breathing rate of 39.2°C and 42 of breathing per minute, heart rate of 160 beats/min As can be seen from table 3, RMS do not have any negative effect on the health of the calves. Thus, in the control group ill 7 out of 10 calves (70,0%), experienced - 3 and 2 out of 10 calves (about 30.0 and 20.0%, respectively). While the calves of the control group was pereboleli severe, as a result, the waste amounted to about 30.0%, and the safety - 70,0%.

As can be seen from table 4, the RMSE increases the level of metabolic processes and physiological state, and activated nonspecific resistance of the organism calves that have led to increased viability of calves and lower their case.

Example 3. According to the principle analogues formed 3 groups of newborn calves 10 goals each. All animals are healthy, normally developed, and the difference in average live weight did not exceed 2%. Calves - antideprin in accordance with instructions on their use. The results are presented in table 5.

As can be seen from table 5, the claimed means in comparison with known had a more pronounced performance, which was reflected in the indicators of safety and duration of illness. The use of powder RMS excluded the possibility of a recurrence of the disease and its transition into the chronic form.

Clinical data obtained in the research and production experience, has shown that RMS when applied inside the calves from the first day after birth and within 20-30 minutes before the second feeding colostrum within 10 days of digestion and metabolism, and increases the activity of protective forces of an organism, therefore, can be used as a means of preventive therapy in gastrointestinal disease with a symptom of diarrhea.

Sources of information

1. Guidance on the application of antidiarrhea in veterinary medicine, appr. Department of veterinary Mysilpada Russia 10.05.2000, No. 13-5-2, 1987.

2. Instruction for use pectocarya in veterinary medicine, appr. Department of veterinary Mysilpada Russia 10.05.2000, No. 13-5-2, 1990.

Application scorepage cattle.



 

Same patents:

The invention relates to medicine, gastroenterology, and can be used for the treatment of diseases associated with infection of the colon bacterium C. difficile, and the formation of colonies resistant to vancomycin enterococci
The invention relates to medicine

The invention relates to biotechnology and characterizes the phytase, the DNA fragment encoding the phytase, an expression vector containing the DNA fragment

The invention relates to veterinary
The invention relates to biotechnology
The invention relates to medicine, namely to diseases of the digestive system, and can be used for treatment of a dysbacteriosis of intestines

The invention relates to a new 2-{4-[4-(4,5-dichloro-2-Mei-1-yl)butyl]-1-piperazinil}-5-torpedinidae formula I (see

The invention relates to medicine, specifically to new substituted N-sintramienergetica, stimulating peristalsis and which may find application in the treatment of intestinal atony

The invention relates to veterinary
The invention relates to the creation of homeopathic ophthalmological funds

The invention relates to medicine, biopharmacology, pharmaceutical chemistry and relates to a tool and method for the treatment of patients with substance dependence

The invention relates to biopharmacology and comes to obtain the aimed at restoring metabolic processes and correction functions of the immune system

The invention relates to biopharmacology and medicine and relates to funds with immunotropic and metabolic action

The invention relates to genetic engineering and can be used for therapeutic purposes, in particular in the treatment of neoplastic processes

The invention relates to the field of creation of means of plant origin and may be used as sedatives in adults with various neuropathic reactions, accompanied by irritability, insomnia, anxiety, fear, etc

The invention relates to the field of creation of biologically active additives and can be used as a General tonic antihypoxic contribute to a reduction of toxic effects of alcohol

The invention relates to a pharmacy, namely the creation of herbal medicines, exhibiting antifungal activity
The invention relates to pharmaceutical industry and relates to the creation of tools, plant-based, and can be used as a therapeutic and preventive antiaggregatory, cardio, ventunesimo and improves microcirculation funds in vascular disorders

FIELD: medicine, cardiology, phytotherapy, pharmacy.

SUBSTANCE: invention relates to the field in development of an agent of vegetable origin used for improvement of the functional state and prophylaxis of organic alterations in cardiovascular system, in particular, atherosclerosis. The biologically active supplement used for prophylaxis of cardiovascular diseases, in particular, atherosclerosis comprises clover dry extract, haw-thorn flowers powder, ascorbic and nicotinic acids, and accessory substances taken in the definite ratio. The biologically active supplement is made in the form of tablet or capsule. No adverse responses observed in intake of the supplement. The blood cholesterol level was reduced to the normal value in 68% of patients and reducing morbidity with acute respiratory-viral infections has been noticed. In patients with ischemic heart disease with cholesterolemia the improvement of the state is noted on the background of conventional therapy: the moderate reducing the arterial pressure value in its elevation, improved in the state of health, enhanced working capacity, reduced retrosternal pains, ear noise, vertigo, headache.

EFFECT: valuable medicinal properties of supplement.

1 ex

Up!